- Erratum
-
- KMID: 2537556
- Blood Res.
- 2022 Dec;57(4):297-297.
- doi: 10.5045/br.2022.2022089e1
-
- CITED
-
- Close
- SHARE
-
- Close
- NK-cell trogocytosis of CD19 antigen: a rare B-ALL MRD mimicker
-
Panda D, Pathak A, Tejwani N, Mehta A
- KMID: 2537546
- Blood Res.
- 2022 Dec;57(4):249-249.
- doi: 10.5045/br.2022.2022235
-
- CITED
-
- Close
- SHARE
-
- Close
- Red blood cells from COVID-19 patients suffer from increased oxidative stress and may have increased lactate influx
-
Mullen E, Bergin S, Healy G, Quinn J, Glavey S, Murphy PT
- KMID: 2537555
- Blood Res.
- 2022 Dec;57(4):294-296.
- doi: 10.5045/br.2022.2022084
-
- CITED
-
- Close
- SHARE
-
- Close
- Various inclusions in chronic lymphocytic leukemia/small lymphocytic lymphoma
-
Galiacho VR, Olmedo AL, Arzuaga-Mendez J, García-Ruiz JC
- KMID: 2537544
- Blood Res.
- 2022 Dec;57(4):247-247.
- doi: 10.5045/br.2022.2022120
-
- CITED
-
- Close
- SHARE
-
- Close
- Unusual peripheral T-cell lymphoma, displaying NOS and flower cells in the blood, and CNS involvement
-
Gross Z, Baseggio L
- KMID: 2537545
- Blood Res.
- 2022 Dec;57(4):248-248.
- doi: 10.5045/br.2022.2022204
-
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of serum and urine free light chain analysis in clinical diagnosis
-
Cho J, Lee DH, Yoo G, Kim J, Uh Y
- KMID: 2537553
- Blood Res.
- 2022 Dec;57(4):284-289.
- doi: 10.5045/br.2022.2022187
-
- CITED
-
- Close
- SHARE
-
- Close
- Detection of NUP214-ABL1 translocation using BCR-ABL1 dual color FISH probes in T-cell acute lymphoblastic leukemia–an illustrative report and review of literature
-
Virk H, Sreedharanunni S, Palla S, Rastogi P, Rathore S, Anshu A, Trehan A
- KMID: 2537551
- Blood Res.
- 2022 Dec;57(4):278-281.
- doi: 10.5045/br.2022.2022134
-
- CITED
-
- Close
- SHARE
-
- Close
- Rapid development of lower leg compartment syndrome following firearm injury in a patient with moderate hemophilia B
-
Bodrozic J, Lekovic D, Koncar I, Dzelatović NS, Miljić P
- KMID: 2537552
- Blood Res.
- 2022 Dec;57(4):281-284.
- doi: 10.5045/br.2022.2022112
-
- CITED
-
- Close
- SHARE
-
- Close
- High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea
-
Kong JH, Jang JY, Ko TH, Kang SH, Kim Y
- KMID: 2537554
- Blood Res.
- 2022 Dec;57(4):290-293.
- doi: 10.5045/br.2022.2022099
-
- CITED
-
- Close
- SHARE
-
- Close
- Epigenetic and genetic investigation of SOCS-1 gene in patients with multiple myeloma
-
Tuncel FC, Serin I, Pehlivan S, Oyaci Y, Pehlivan M
- KMID: 2537547
- Blood Res.
- 2022 Dec;57(4):250-255.
- doi: 10.5045/br.2022.2022097
Background The suppressor of cytokine signaling-1 (SOCS-1) functions to induce an appropriate immune response and is an essential physiological regulator of interferon signaling. DNA methylation involves adding a methyl group to... -
- CITED
-
- Close
- SHARE
-
- Close
- Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis
-
Kim DH, Seo J, Shin DY, Koh Y, Hong J, Kim I, Yoon SS, Byun JM
- KMID: 2537549
- Blood Res.
- 2022 Dec;57(4):264-271.
- doi: 10.5045/br.2022.2022194
Background Allogeneic hematopoietic stem cell transplantation (alloSCT) is the sole curative option for myelofibrosis (MF). However, it is unknown as to which of the two, myeloablative conditioning (MAC) or reduced-intensity conditioning... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic impact of total body irradiation dose in pediatric acute lymphoblastic leukemia patients treated with allogeneic hematopoietic stem cell transplantation in second complete remission
-
Jang W, Jo S, Yoo JW, Kim S, Lee JW, Jang PS, Chung NG, Cho B
- KMID: 2537548
- Blood Res.
- 2022 Dec;57(4):256-263.
- doi: 10.5045/br.2022.2022174
Background Allogeneic HSCT may improve survival in pediatric ALL patients who relapse. In this study, we analyzed the outcome and prognostic factors of 62 ALL patients (35 male, 56.5%) who received... -
- CITED
-
- Close
- SHARE
-
- Close
- FVIII inhibitor surveillance in children with hemophilia A in Indonesia: a report from the Indonesian Pediatric Hematology-Oncology Working Group
-
Chozie NA, Gatot D, Sudarmanto B, Susanah S, Purnamasari R, Widjajanto PH, Nugroho S, Rasiyanti O, Puspitasari D, Riza M, Shanty Larasati MC, Adiyanti SS, Saraswati MC, Primacakti F, on behalf of the Pediatric Hematology-Oncology Working Group of the Indonesian Pediatric Society
- KMID: 2537550
- Blood Res.
- 2022 Dec;57(4):272-277.
- doi: 10.5045/br.2022.2022153
Background Factor VIII (FVIII) inhibitor diagnosis and surveillance in Indonesia are challenging owing to geographic conditions and the lack of laboratory facilities nationwide for inhibitor assays. This study aimed to determine... -
- CITED
-
- Close
- SHARE
-
- Close
